May 2017 Newsletter

May 23, 2017:

ASCRS Pays Tribute to Phaco at 50, Honors Kelman, Other Early Pioneers

Sessions highlighted the technology’s impact on eye care.

May 23, 2017:

pSivida Adopts New Business Model to Become Profitable

The drugmaker plans to market its own ophthalmic products rather than license them to others.

May 23, 2017:

LensGen Closes $21 Million Series A Financing from Hoya

The company is developing Juvene, an accommodating IOL.

May 23, 2017:

Trial for James Mazzo Ends in Hung Jury; Co-defendants DeCinces, Parker Convicted

Government’s case hinged on timing of phone calls and trades rather than evidence of what was said.

May 23, 2017:

Allergan Receives US FDA Clearance for TrueTear Neurostimulator for Dry Eye

The company acquired the Oculeve technology in 2015.

May 23, 2017:

Bausch + Lomb Gains US FDA Clearance for Vitesse Hypersonic Vitrectomy System

Device provides 1.5 million pulses per minute.

May 23, 2017:

LENSAR Becomes Subsidiary of PDL, Gains FDA Clearance for Laser Integration with Pentacam, Aladdin

The move completes LENSAR’s financial restructuring after separating from Alphaeon.

May 23, 2017:

FDA Approves Genentech’s Lucentis for All Forms of Diabetic Retinopathy

The VEGF inhibitor is the first to gain this indication in the US market.

May 23, 2017:

Ophtec Secures CE Mark Approval for Aspheric Presbyopia-Correcting IOL

The lens will be commercially launched in October 2017 at the annual conference of the ESCRS.

May 23, 2017:

2017 ASCRS Meeting: Surgeons Report Benefits of FLACS in Complicated Cases; Company Leaders Optimistic over Future

Despite ongoing debate, surgeons continue to adopt technology.

May 23, 2017:

2017 ASCRS Meeting: J&J Vision’s TECNIS Symfony EDOF IOL Dominates Sessions

Speakers also discussed next-generation accommodating and component IOLs.

May 23, 2017:

2017 ASCRS Meeting: More Sessions Devoted to Glaucoma Surgery, Approved MIGS Devices

The meeting focused on choosing the best surgical treatment from the growing number of options.

May 23, 2017:

2017 ASCRS Meeting: Dry Eye Sessions Focus on Xiidra, TrueTear; Pipeline Crowded with Prospects

Firms in late-stage development include Sun Pharma and Kala Pharmaceuticals.

May 23, 2017:

2017 ASCRS Meeting: PROWL-2 LASIK Study, SMILE Results are Focus of Refractive Sessions

The Zeiss booth was a popular destination, with many surgeons test driving VisuMax systems.

May 23, 2017:

2017 ASCRS Meeting: Speakers Describe Progress with Corneal Inlays, Scleral Implants

Phase I/II data for Encore Vision’s eye drop showed promise.

May 23, 2017:

2017 ASCRS Meeting: Former Oculeve CEO Receives OIS Innovator Award

Michael Ackermann, PhD, helped develop the dry eye neurostimulator purchased by Allergan and renamed TrueTear.

May 23, 2017:

2017 ASCRS Meeting: Jesse Dovich, MD, Wins Tesla Model S

The drawing was held May 8 at the exhibit hall.

May 23, 2017:

Market Report: Expanding Premium Lens Technology to Fuel 8.4 Percent Growth in IOL Market

More than 31 million IOLs will be implanted by 2022, as industry becomes increasingly complex.

May 23, 2017:

Market Report: Ocular Coherence Tomography Market to Generate $697 Million in 2017

Revenues in the segment are expected to grow 4.4 percent over the next five years.

May 23, 2017:

Alcon Revenues Increase 1 Percent in Q1-2017 Amid Turnaround Effort

Novartis plans to release the results of its strategic review of Alcon toward the end of 2017.

May 23, 2017:

Allergan’s Restasis Sales Rise 3.4 Percent in Q1-2017

The dry eye treatment continues to increase sales volume, despite the successful market entry of Shire’s Xiidra.

May 23, 2017:

Bausch + Lomb Posts Q1-2017 Revenues of $1.15 Billion in ‘Solid Quarter’

Valeant’s eye care segment now accounts for more than half of total company revenues.

May 23, 2017:

Q1-2017 Earnings Briefs

May 23, 2017:

Visionary Venture Fund to Invest $30 Million in Ophthalmic Firms

Its portfolio companies include IanTech, Mynosys, SightLife Surgical, and RxSight.

May 23, 2017:

Market Scope Weekly Polls

May 23, 2017:

Alcon Launches CyPass MIGS Device in European Union

The device is now available in the UK, Germany, Italy, and Spain.

May 23, 2017:

Gottlieb Says US FDA Can Help Reduce Drug Prices through Generics, Biosimilars

The US Senate voted 57 to 42 to confirm Gottlieb as FDA commissioner on May 9.

May 23, 2017:

Retina Specialist Melgen Convicted of 67 Counts of Medicare Fraud

Melgen was taken into custody immediately and awaits sentencing July 14.

May 23, 2017:

May 2017 News Briefs

Social media